With cancer a leading cause of death in Japan, the market for pharmaceuticals to treat tumors is expected to grow by 5% by 2023, and to represent one fifth of the market for pharmaceuticals by 2026. The prediction is part of a... Read More
Attracted by Shanghai government policies designed to encourage the development of the pharmaceutical industry, Western drug manufacturers are setting up shop in China’s financial hub. The biopharmaceutical firms are partnering with Chinese industry leaders, taking advantage of a reservoir of talented biopharma... Read More
With cancer a leading cause of death in Korea, the government plans to harness the power of big data to tackle the disease by increasing information sharing among healthcare institutions to bolster diagnosis, treatment, and research. At a meeting of the Korea... Read More
Currently the third-largest pharmaceutical market in the world, Japan presents many opportunities for foreign drug companies. Major factors such as a rising incidence of chronic diseases and a rapidly aging population have contributed to the pharmaceutical market growth. Excipient manufacturers can also benefit... Read More
Plans by China to create a free trade port in Hainan province, which have moved forward swiftly this year, bolster opportunities for the growth of the country’s pharmaceutical industry. They are also likely to lower prices on imports for Chinese consumers who... Read More
Low insurance reimbursement rates in Taiwan are discouraging the development of innovative pharmaceutical products, according to a study by Fitch Solutions. Because essential healthcare for all residents of the island nation is covered by a single public system, and hospitals negotiate with... Read More
The viability of marketing home-use genetic collection kits to consumers in Asian markets is growing, bolstered by government incentives, increased consumer awareness of their own healthcare needs and improvements in the technology behind the kits themselves. The kits employ state of the... Read More
With China ahead of other major global economic powers in its recovery from the COVID-19 pandemic, its biopharmaceutical industry is surging, driven by its increased capacity for research and development, growing investment in the sector from venture capital firms and a series... Read More
With the COVID-19 pandemic driving growing demand for digital health services, Hong Kong’s government has begun to take some steps to foster telehealth offerings, mobile healthcare apps, and increased use of digital technologies in hospitals and outpatient clinics. The developments include the... Read More
The combination of a relatively low–cost workforce and increasingly reliable quality and ethical standards is turning the Asia-Pacific region into a hub for clinical trials. With pharmaceutical firms under growing pressure to provide innovative new products at reasonable prices, the region is becoming more... Read More